Ho PL - Search Results

1

Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance.

Kurtova AV, Xiao J, Mo Q, Pazhanisamy S, Krasnow R, Lerner SP, Chen F, Roh TT, Lay E, Ho PL, Chan KS. Kurtova AV, et al. Among authors: ho pl. Nature. 2015 Jan 8;517(7533):209-13. doi: 10.1038/nature14034. Epub 2014 Dec 3. Nature. 2015. PMID: 25470039 Free PMC article.

2

Normal and neoplastic urothelial stem cells: getting to the root of the problem.

Ho PL, Kurtova A, Chan KS. Ho PL, et al. Nat Rev Urol. 2012 Oct;9(10):583-94. doi: 10.1038/nrurol.2012.142. Epub 2012 Aug 14. Nat Rev Urol. 2012. PMID: 22890301 Free PMC article. Review.

3

Stat3 activation in urothelial stem cells leads to direct progression to invasive bladder cancer.

Ho PL, Lay EJ, Jian W, Parra D, Chan KS. Ho PL, et al. Cancer Res. 2012 Jul 1;72(13):3135-42. doi: 10.1158/0008-5472.CAN-11-3195. Epub 2012 Apr 24. Cancer Res. 2012. PMID: 22532166 Free PMC article.

4

Positive association of collagen type I with non-muscle invasive bladder cancer progression.

Brooks M, Mo Q, Krasnow R, Ho PL, Lee YC, Xiao J, Kurtova A, Lerner S, Godoy G, Jian W, Castro P, Chen F, Rowley D, Ittmann M, Chan KS. Brooks M, et al. Among authors: ho pl. Oncotarget. 2016 Dec 13;7(50):82609-82619. doi: 10.18632/oncotarget.12089. Oncotarget. 2016. PMID: 27655672 Free PMC article.

5

Three differentiation states risk-stratify bladder cancer into distinct subtypes.

Volkmer JP, Sahoo D, Chin RK, Ho PL, Tang C, Kurtova AV, Willingham SB, Pazhanisamy SK, Contreras-Trujillo H, Storm TA, Lotan Y, Beck AH, Chung BI, Alizadeh AA, Godoy G, Lerner SP, van de Rijn M, Shortliffe LD, Weissman IL, Chan KS. Volkmer JP, et al. Among authors: ho pl. Proc Natl Acad Sci U S A. 2012 Feb 7;109(6):2078-83. doi: 10.1073/pnas.1120605109. Epub 2012 Jan 19. Proc Natl Acad Sci U S A. 2012. PMID: 22308455 Free PMC article.

6

Immune therapies in non-muscle invasive bladder cancer.

Ho PL, Williams SB, Kamat AM. Ho PL, et al. Curr Treat Options Oncol. 2015 Feb;16(2):5. doi: 10.1007/s11864-014-0315-3. Curr Treat Options Oncol. 2015. PMID: 25757877 Review.

7

Outcome of patients with clinically node-positive bladder cancer undergoing consolidative surgery after preoperative chemotherapy: The M.D. Anderson Cancer Center Experience.

Ho PL, Willis DL, Patil J, Xiao L, Williams SB, Melquist JJ, Tart K, Parikh S, Shah JB, Delacroix SE, Navai N, Siefker-Radtke A, Dinney CP, Pisters LL, Kamat AM. Ho PL, et al. Urol Oncol. 2016 Feb;34(2):59.e1-8. doi: 10.1016/j.urolonc.2015.08.012. Epub 2015 Oct 1. Urol Oncol. 2016. PMID: 26421586

8

Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical Cystectomy.

Kukreja JB, Porten S, Golla V, Ho PL, Noguera-Gonzalez G, Navai N, Kamat AM, Dinney CPN, Shah JB. Kukreja JB, et al. Among authors: ho pl. Eur Urol Focus. 2018 Sep;4(5):720-724. doi: 10.1016/j.euf.2016.12.005. Epub 2017 Jan 18. Eur Urol Focus. 2018. PMID: 28753837

9

In-vitro cytocidal effect of water on bladder cancer cells: The potential role for intraperitoneal lavage during radical cystectomy.

Taoka R, Williams SB, Ho PL, Kamat AM. Taoka R, et al. Among authors: ho pl. Can Urol Assoc J. 2015 Mar-Apr;9(3-4):E109-13. doi: 10.5489/cuaj.2435. Can Urol Assoc J. 2015. PMID: 25844095 Free PMC article.

10

A 60-year-old woman with an incidentally discovered right renal mass.

Stamatakis L, Cheng PJ, Ho PL, Thrall MJ, Mayer WA, Miles BJ, Link RE. Stamatakis L, et al. Among authors: ho pl. Urology. 2012 Dec;80(6):1183-6. doi: 10.1016/j.urology.2012.08.052. Urology. 2012. PMID: 23206761 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

636 results

Search Page

Filters